Literature DB >> 1757557

Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

B E Anderson1, J E Dawson, D C Jones, K H Wilson.   

Abstract

The bacterial 16S rRNA genes from blood samples of two patients with human ehrlichiosis and from an isolate recovered from one of the patients were amplified by using the polymerase chain reaction. The amplimers were then cloned and sequenced. The 16S rRNA gene sequence was also determined for Ehrlichia canis (two strains), E. equi, E. phagocytophila (two strains), and E. sennetsu (two strains). These sequences, along with a previously published 16S rRNA gene sequence of E. risticii, were compared. The 16S rRNA gene sequences were identical for all three sources of the human ehrlichiosis agent. The sequence comparisons indicate that the human ehrlichiosis agent is a new species most closely related to E. canis (98.2%) and more distantly related to other Ehrlichia spp. We propose that this species be named Ehrlichia chaffeensis sp. nov., with the Arkansas strain as the type strain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757557      PMCID: PMC270443          DOI: 10.1128/jcm.29.12.2838-2842.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction.

Authors:  K H Wilson; R B Blitchington; R C Greene
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 2.  Bacterial evolution.

Authors:  C R Woese
Journal:  Microbiol Rev       Date:  1987-06

3.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

4.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

5.  Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology.

Authors:  T Tzianabos; B E Anderson; J E McDade
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Equine ehrlichiosis: a disease with similarities to tick-borne fever and bovine petechial fever.

Authors:  A A Stannard; D H Gribble; R S Smith
Journal:  Vet Rec       Date:  1969-02-08       Impact factor: 2.695

7.  Adaptation of Ehrlichia sennetsu to canine blood monocytes: preliminary structural and serological studies with cell culture-derived Ehrlichia sennetsu.

Authors:  C J Holland; M Ristic; D L Huxsoll; A I Cole; G Rapmund
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Unexplained febrile illnesses after exposure to ticks. Infection with an Ehrlichia?

Authors:  D B Fishbein; L A Sawyer; C J Holland; E B Hayes; W Okoroanyanwu; D Williams; K Sikes; M Ristic; J E McDade
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

10.  Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates.

Authors:  J E Dawson; Y Rikihisa; S A Ewing; D B Fishbein
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  158 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Identification of Ehrlichia chaffeensis by nested PCR in ticks from Southern China.

Authors:  W C Cao; Y M Gao; P H Zhang; X T Zhang; Q H Dai; J S Dumler; L Q Fang; H Yang
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Granulocytic ehrlichiosis in two dogs in Switzerland.

Authors:  N Pusterla; J Huder; C Wolfensberger; B Litschi; A Parvis; H Lutz
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Molecular cloning of the gene for a conserved major immunoreactive 28-kilodalton protein of Ehrlichia canis: a potential serodiagnostic antigen.

Authors:  J W McBride; X j Yu; D H Walker
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

5.  Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.

Authors:  R E Barnewall; N Ohashi; Y Rikihisa
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Ehrlichiosis in a visitor to Virginia.

Authors:  R W Armstrong
Journal:  West J Med       Date:  1992-08

7.  Analysis of p51, groESL, and the major antigen P51 in various species of Neorickettsia, an obligatory intracellular bacterium that infects trematodes and mammals.

Authors:  Yasuko Rikihisa; Chunbin Zhang; Manuel Kanter; Zhihui Cheng; Norio Ohashi; Takeo Fukuda
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis.

Authors:  J S Daly; M G Worthington; D J Brenner; C W Moss; D G Hollis; R S Weyant; A G Steigerwalt; R E Weaver; M I Daneshvar; S P O'Connor
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.